US 12,133,990 B2
Wearable therapeutic device
Emil Oskin, Natrona Heights, PA (US); Philip C. Skalos, Munhall, PA (US); and Thomas E. Kaib, Irwin, PA (US)
Assigned to ZOLL MEDICAL CORPORATION, Chelmsford, MA (US)
Filed by ZOLL MEDICAL CORPORATION, Chelmsford, MA (US)
Filed on Jun. 14, 2023, as Appl. No. 18/209,549.
Application 18/209,549 is a continuation of application No. 17/938,767, filed on Oct. 7, 2022, granted, now 11,717,693.
Application 17/938,767 is a continuation of application No. 17/143,376, filed on Jan. 7, 2021, granted, now 11,504,541, issued on Nov. 22, 2022.
Application 17/143,376 is a continuation of application No. 16/751,466, filed on Jan. 24, 2020, granted, now 10,926,098, issued on Feb. 23, 2021.
Application 16/751,466 is a continuation of application No. 16/257,854, filed on Jan. 25, 2019, granted, now 10,589,110, issued on Mar. 17, 2020.
Application 16/257,854 is a continuation of application No. 14/630,947, filed on Feb. 25, 2015, granted, now 10,226,638, issued on Mar. 12, 2019.
Application 14/630,947 is a continuation of application No. 13/315,894, filed on Dec. 9, 2011, granted, now 9,007,216, issued on Apr. 14, 2015.
Claims priority of provisional application 61/530,585, filed on Sep. 2, 2011.
Claims priority of provisional application 61/421,970, filed on Dec. 10, 2010.
Prior Publication US 2023/0321453 A1, Oct. 12, 2023
Int. Cl. A61N 1/39 (2006.01); A61B 5/00 (2006.01); A61B 5/318 (2021.01); A61N 1/04 (2006.01)
CPC A61N 1/3918 (2013.01) [A61B 5/318 (2021.01); A61B 5/6804 (2013.01); A61N 1/04 (2013.01); A61N 1/0484 (2013.01); A61N 1/3968 (2013.01); A61N 1/3993 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A wearable device for externally applied electrical treatment, comprising:
a belt configured to be worn about a torso of a subject;
at least one therapy electrode housed in the belt;
an electrocardiogram (ECG) sensing electrode; and
a controller comprising at least one processor, the controller being configured to
determine whether the at least one therapy electrode is properly positioned to apply electrical treatment to the subject,
cause a monitor operatively coupled to the controller to audibly, visually, or haptically notify the subject of improper positioning of the at least one therapy electrode responsive to determining the at least one therapy electrode is not properly positioned to apply the electrical treatment to the subject,
detect, via the ECG sensing electrode, cardiac distress occurring in the subject, and
instruct the electrical treatment be applied to the subject via the at least one therapy electrode responsive to
determining the cardiac distress is detected, and
confirming that the at least one therapy electrode is properly positioned.